فصلنامه نفس

Covid W. Dashboard. Geneva: World Health Organization. 2020;2020.

Jamaati H, Karimi S, Ghorbani F, et al. Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in Iran. Journal of Medical Virology. 2023;95(3):e28607.

Abdollahi A, Naseh I, Kalroozi F, et al. Potential adverse effects of covid-19 vaccines on Iranian healthcare workers: Comparison of four available vaccines in Tehran: A retrospective cross-sectional study. Oman Medical Journal. 2023;38(2):e486.

covid19.trackvaccines.org [Internet]. Covid19 vaccine tracker. Iran (Islamic Republic of). [Updated Dec. 2, 2022] Available from: https://covid19.trackvaccines.org/country/iran-islamic-republic-of

Babaee E, Amirkafi A, Tehrani-Banihashemi A, et al. Adverse effects following COVID-19 vaccination in Iran. BMC Infectious Diseases. 2022;22(1):476.

Kaur RJ, Dutta S, Bhardwaj P, et al. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian Journal of Clinical Biochemistry. 2021;36(4):427-439.

Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, et al. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Scientific reports. 2021;11(1):21464.

Jamaati H, Karimi S, Arshi S, et al. Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis. Frontiers in Immunology. 2025; 16:1504973. doi: 10.3389/fimmu.2025.1504973

Montalti M, Soldà G, Di Valerio Z, et al. ROCCA study protocol and interim analysis on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino: An observational study using active surveillance. medRxiv. 2021:2021.2005. 2003.21256509.

Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. 2021;385(12):1078-1090.

Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases. 2021;21(7):939-949.

Rosenblum HG, Gee J, Liu R, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. The Lancet Infectious Diseases. 2022;22(6):802-812.

Pagotto V, Ferloni A, Soriano MM, et al. Active monitoring of early safety of Sputnik V vaccine in Buenos Aires, Argentina. MEDICINA (Buenos Aires). 2021;81(3):408-414.

El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. International journal of general medicine. 2021:1389-1401.

Ganesan S, Al Ketbi LMB, Al Kaabi N, et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE—an observational study. Frontiers in Public Health. 2022;10:876336.

Cushman M, editor. Epidemiology and risk factors for venous thrombosis. Seminars in Hematology. 2007;44(2):62-69.

Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis. Thrombosis Journal. 2021;19(1):1-9.